Clinical Trials Directory

Trials / Completed

CompletedNCT02509299

Effect of Physiotherapy in Hospitalized COPD Patients

Effect of Different Physiotherapy Treatments in Hospitalized COPD Patients

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
49 (actual)
Sponsor
Universidad de Granada · Academic / Other
Sex
All
Age
40 Years
Healthy volunteers
Not accepted

Summary

Chronic obstructive pulmonary disease (COPD) impacts negatively on the balance and strength of patients. Several studies have shown that acute exacerbations (AEs) decrease, pulmonary function and survival of COPD patients, and there are a lot of physiotherapy interventions to improve it during the hospital stay. The objective of the present study is to examine the effects of a physical therapy program on balance and strength in COPD patients hospitalized due to acute exacerbation.

Detailed description

Chronic obstructive pulmonary disease (COPD) is a major cause of morbidity and mortality worldwide. It is a progressive disease, characterized by lung function impairment with airway obstruction. Patients with COPD suffer exacerbations; the frequency of these exacerbations increases with the severity of the disease. It has been previously shown that the level of health-related quality of life of COPD subjects deteriorates considerably with increasing severity of disease and that the deterioration is linearly related to a decrease in FEV1 % predicted normal values.

Conditions

Interventions

TypeNameDescription
OTHERPhysiotherapy program 1The standard medical treatment and additionally they will receive physiotherapy. The program will be performed every day during the hospital stay and it will include global active range of motion (ROM) exercises and muscle strengthening like upper and lower limbs flexion-extension do single-leg stance, and sit to stand exercises.
OTHERPhysiotherapy program 2COPD patients included in this group will receive the standard medical treatment and additionally, they will receive a physiotherapy program. The program will be performed every day during the hospital stay and included neuromuscular stimulation therapy on quadriceps accompanied by lower limbs exercises
DRUGStandard medical treatmentThe standard medical treatment consists on: * Inhaled bronchodilators: Short acting inhaled β2 agonists ( salbutamol and terbutaline) and anticholinergic agents (ipratropium and oxitropium bromide). * Glucocorticoids: Inhaled glucocorticoids including beclomethasone dipropionate, budesonide, flunisolide, fluticasone propionate and triamcinolone acetonide, depending on the expert criteria. \- Antibiotics: The antibiotics were administered according to the GOLD criteria including the β-lactamase inhibitor and fluoroquinolones.

Timeline

Start date
2019-09-01
Primary completion
2019-11-20
Completion
2019-12-14
First posted
2015-07-28
Last updated
2020-01-27

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT02509299. Inclusion in this directory is not an endorsement.